Documents
United States Pharmacopeia (USP) Allowable Adjustments Guide
Quickly view the allowable adjustments that have been outlined by the United States Pharmacopeia (USP) and then select the proper Phenomenex column for your monograph using this simple guide.
United States Pharmacopeia (USP) Allowable Adjustments Guide
Quickly view the allowable adjustments that have been outlined by the United States Pharmacopeia (USP) and then select the proper Phenomenex column for your monograph using this simple guide.
Document Type:
Brochures
Target Industries:
Techniques:
Brands:
Separation Modes:
Chiral, Normal Phase, HILIC, Ion-Exchange
Phases:
Aeris Peptide XB-C18, Aeris Widepore C4, Aeris Widepore XB-C18, Aeris Widepore XB-C8, Clarity Oligo-MS, Clarity Oligo-RP, Clarity Oligo-XT, Gemini C18, Gemini C6-Phenyl , Gemini NX-C18, Kinetex Biphenyl, Kinetex C18, Kinetex EVO C18, Kinetex F5, Kinetex HILIC, Kinetex Phenyl-Hexyl, Kinetex Polar C18, Kinetex XB-C18, Luna C18(2), Luna C8(2), Luna CN , Luna HILIC, Luna NH2, Luna Omega C18, Luna Omega PS C18, Luna Omega Polar C18, Luna PFP(2) , Luna Phenyl-Hexyl, Luna SCX, Luna Silica(2), Lux Amylose-1, Lux Cellulose-1, Lux Cellulose-3 , Lux i-Amylose-1, Onyx Monolithic C8, Onyx Monolithic C18, RCM-Monosaccharide Ca+2 (8%) , RCU-USP Sugar Alcohols Ca, RHM-Monosaccharide H+ (8%), RNM-Carbohydrate Na+, ROA-Organic Acid H+ (8%) , RPM-Monosaccharide Pb+2, Synergi Hydro-RP, Synergi Max-RP, Synergi Polar-RP, Yarra SEC-2000, Yarra SEC-3000 , Yarra SEC-X150, Yarra SEC-X300, Biosep SEC-s2000, bioSep-SEC-s3000
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
